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Background: In Germany, clinical trials and comparative effectiveness studies in primary care are still very rare,
while their usefulness has been recognised in many other countries. A network of researchers from German
academic general practice has explored the reasons for this discrepancy.
Methods: Based on a comprehensive literature review and expert group discussions, problem analyses as well as
structural and procedural prerequisites for a better implementation of clinical trials in German primary care are
presented.
Results: In Germany, basic biomedical science and technology is more reputed than clinical or health services
research. Clinical trials are funded by industry or a single national programme, which is highly competitive,
specialist-dominated, exclusive of pilot studies, and usually favours innovation rather than comparative effectiveness
studies. Academic general practice is still not fully implemented, and existing departments are small. Most general
practitioners (GPs) work in a market-based, competitive setting of small private practices, with a high case load.
They have no protected time or funding for research, and mostly no research training or experience. Good Clinical
Practice (GCP) training is compulsory for participation in clinical trials. The group defined three work packages to be
addressed regarding clinical trials in German general practice: (1) problem analysis, and definition of (2) structural
prerequisites and (3) procedural prerequisites. Structural prerequisites comprise specific support facilities for general
practice-based research networks that could provide practices with a point of contact. Procedural prerequisites
consist, for example, of a summary of specific relevant key measures, for example on a web platform. The platform
should contain standard operating procedures (SOPs), templates, checklists and other supporting materials for
researchers.
Conclusion: All in all, our problem analyses revealed that a substantial number of barriers contribute to the low
implementation of clinical research in German general practice. Some issues are deeply rooted in Germany’s
market-based healthcare and academic systems and traditions. However, new developments may facilitate change:
recent developments in the German research landscape are encouraging.
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Research in general practice is fundamental to ensure
patient safety and efficient patient care. Recently, there
has been increasing awareness of the need for clinical
trials in primary care settings, or extension of transla-
tional research projects into everyday primary care,
which can provide evidence with significant impact on
public health. Translating research ‘from the ivory tower
to the village green’ (Chris van Weel) is essential to
make research findings useful for the population, but
requires sufficient infrastructure and funding opportun-
ities [1-5]. In the US, major funding programmes have
been launched to facilitate comparative effectiveness
studies, many of which are expected to be primary care-
based or to tackle public health needs, and translational
research with an outreach into primary care [6-8]. An
elaborate procedure of citizens’ conferences and discussion
rounds decide the general agenda and those projects of ut-
most interest with maximal support and benefit of the
public [6]. In the UK, primary care clinical trials in so-
called practice-based research networks (PBRNs) are con-
sidered a priority within national funding programmes
and a cornerstone for Britain’s economy [9]. Substantial
efforts have been made to facilitate trials in general prac-
tice settings, including training and accreditation of ‘re-
search ready’ practices, and there is a state-funded
overhead coordination structure for the PRNBs [10,11]. In
the Netherlands and the US, practice-based research net-
works provide continuous high-quality observational data
for health services research, but are also expected to serve
as a platform for clinical trials [12,13]. The UK-led Euro-
pean TRANSFoRm project aims to interlink and extend
existing databases of electronic patient records, and to
provide electronic support to practice networks in order
to facilitate clinical trials and comparative effectiveness re-
search in primary care [14,15]. Usually, practice-based re-
search networks cooperate closely with specific coordinating
centres, often academic departments for general practice, or
specific, publicly funded research institutes for primary
health care research.
In Germany, fundamental biomedical research and
technological development are the strongholds of medi-
cal research. By comparison, clinical trials are still under-
represented. This need has been recognised by stakeholders
in research policy. To address this, a single national funding
programme has been launched [16]. All clinical specialities
(including general practice) can apply for funding in this
highly competitive programme; the reviewer group is multi-
disciplinary and international. Similarly, a federal start-up
funding programme has instigated a number of coordi-
nation centres for clinical trials, which are mostly based at
universities/medical faculties. Interdisciplinary teams pro-
vide expertise and services related to the development of
study protocols, administrative procedures and contractmanagement, monitoring and biometry. After a few years
of initial funding, however, these centres now have to be
self-sustaining. Consequently, they rely heavily on industry-
funded studies and investigator-initiated, low-budget trials
are hampered. Moreover, the coordination centres are usu-
ally not familiar with the specific conditions and needs in
primary care settings.
In Germany, clinical research has been almost exclu-
sively based in university or tertiary care hospitals to
date; clinical studies in general practice remain the ex-
ception [4,17-23].
Network group
In 2009, a group of researchers from various academic
departments of general practice interested and involved
in clinical research applied to the German Research
Foundation to fund a network. Their long-term aim is to
facilitate the implementation of clinical trials in primary
care in Germany, increasing the numbers of successful
grant applications and execution of high-quality clinical
trials. The network group defined three work packages
to be addressed regarding clinical trials in German gen-
eral practice: (1) problem analysis, and definition of (2)
structural prerequisites and (3) procedural prerequisites.
This paper presents the main results of the problem ana-
lysis and highlights the next steps for the network and
future development of clinical research in German gen-
eral practice generally.
Methods
According to German Research Foundation rules, net-
work size is limited to a maximum of 15 persons (half of
whom must be junior researchers without a tenured pos-
ition). Funding is intended to enable meetings of the
group and to invite experts [24]. Structural support,
staff, or funding for actual studies is not provided.
Participation in the network group was based on per-
sonal experience and expertise. The group has met face
to face six times so far. In addition to the network mem-
bers, external national or international experts (that is,
on coordination of primary care-based research net-
works or biometry) were involved in some meetings
(present during part of the meeting, or via telephone
conference), or consulted individually by a member. The
work packages (1) problem analysis, and definition of (2)
structural prerequisites and (3) procedural prerequisites
were addressed in an iterative discussion process based
on the group’s own expertise and knowledge as well as a
comprehensive review of published and German grey lit-
erature. The group identified problem areas, which were
then looked at in more detail by small working groups.
Research papers published by German general practice
researchers were sought in Scopus (http://info.scopus.
com) and by hand searching publication lists of general
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referring to prerequisites and circumstances specific to
conducting clinical trials studies in primary care settings
was retrieved in PubMed (2000 to 2012) searching for
the MeSH term ‘Randomized Controlled Trials as Topic’
and keywords ‘primary care/general practice/family
practice’ as well as ‘feasibility’, ‘recruitment’, and ‘design’.
Titles and abstracts were screened to identify papers that
addressed the methodological and circumstantial aspects
of trial conduction and were not merely reporting clin-
ical trial results. Additionally, reference lists of identified
relevant papers were checked. Barriers and facilitators of
successful trial conduction were then compared to the
German setting. The working groups compiled prelimin-
ary results, which were then discussed face to face in the
entire network group, and with the external experts
when appropriate, until consensus was reached.
Results
Problem analysis
Against the background of the German research trad-
ition and the general situation for clinical research out-
lined above, aspects of current funding policies, the
situation of academic general practice as well as some
features of the German health care system were identi-
fied as possible barriers to conducting clinical trials in
German general practice.
Funding of clinical research relevant to general practice
Obtaining funding for investigator-initiated clinical trials
is challenging in Germany. Expenses for clinical trials
are high due to high staff costs and extensive regulatory
requirements. These are applied to any study investigat-
ing pharmacotherapy, including comparative studies of
licensed drugs, and include the obligatory certified
Good Clinical Practice (GCP) training for any trial
physician/participating general practitioner (GP) (the
length of training varies between four hours and several
days, by region). Funding problems may be particularly
acute for pragmatic studies or comparative effectiveness
studies: the vast majority of clinical trials are funded by
the pharmaceutical industry, either as commissioned
contract research, or as investigator-initiated trials at-
tractive to the industrial partner. They are usually run
by highly specialised hospital-based clinicians. In con-
trast, research questions from a primary care perspec-
tive usually carry no substantial financial interest for
industry partners as they often focus on the non-
inferiority of less invasive and/or inexpensive interven-
tions or comparison of established, off-patent therapies
[2]. Examples could be the comparison of different
analgesics or different exercise strategies for musculo-
skeletal pain; different antibiotics for male urinary tract
infections; regular walks in prevention of falls in theelderly; stepping down/stopping of thyroxine treatment
for chronic hypothyroidism/goitre; or diuretic treatment
for chronic heart failure. Research in primary care al-
most exclusively depends on public funding. The federal
Clinical Trials funding programme is highly competitive
and the vast majority of reviewers are hospital-based
specialists. Single-centre trials or pilot studies are not
eligible for funding. Comparative assessment studies or
interventions stepping down treatment tend to be
classed as ‘not contributing to innovation or scientific
advancement’. Funding of clinical trials through other
channels is rare: the high costs of clinical trials (which
include expenses for staff, drugs and service, monitoring
and regulatory requirements) preclude funding by foun-
dations or charities. Sickness funds invest in research
only to a very limited degree and tend to limit projects
to their own clients.Academic environment and situation of academic general
practice
Germany lacks a long-standing tradition of primary care re-
search [26,27]. Academic departments of general practice/
family medicine or primary health care have been created
comparatively recently (starting in the late 1970s), and are
still not universal today. Currently, approximately two-
thirds of the German medical schools have a full academic
department of general practice, usually with a single profes-
sor and a few staff members. In many universities, academic
GPs are not paid as physicians, but receive a considerably
lower ‘researcher fee’ as they are not considered to directly
contribute to patient care in the university hospital.
An overview of barriers for clinical trials initiated by
academic general practice (and academic general prac-
tice research in general), identified within the structure
and tradition of German universities and medical facul-
ties, is shown below.
Problems and barriers at the university level in German
general practice:
Medical faculties
 Research profiles of medical faculties expected to
focus on a few specific research fields: little
awareness and little compatibility of general practice
principles and research agenda with most
universities’ current research priorities [28].
 University hospitals are aiming to be profitable,
opening new ‘business areas’ in a market-oriented
health care system. Primary care is not perceived as
a profitable research field.
 University hospitals (and thus medical faculties)
compete with general practitioners (GPs) for some
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establish their own primary care facilities in
competition with traditional practices, resulting in a
conflict of interest for academic and collaborating GPs.
 Coordination centres for clinical trials need to fund
themselves (after a publicly funded starting period of a
few years). They usually have no experience with
(research in) primary care. Good Clinical Practice
(GCP) training is run as a self-funded (or commercial)
activity, focused on hospital-based research.
 Universities/academic departments of general
practice or the German College of General Practice/
Family Medicine are not formally involved in
vocational training of GPs, which is under the
auspices of the regional chambers of physicians.
Thus, research is not a part of vocational training,
and awareness of primary care research as well as
evidence-based medicine remains quite low [29].
One exception is the state of Baden Wurttemberg,
where the regional government established a
coordination centre for vocational training at an
academic department of general practice.Academic departments of general practice
 Usually small, mostly ‘first generation’, without a
long-standing research tradition
 Few trained general practice researchers (the overall
number of GPs with a PhD degree is still less than
30)
 Limited experience in clinical trials
 No funding or (stable) support structure for
research practices/practice-based research networks
Most academic departments collaborate with a number
of general practices in their area, which are contracted to
receive and teach undergraduate students. These teaching
GPs are not considered university staff; they receive a small
service-based fee for teaching but not for train-the-trainer
activities. Training and supervision is usually provided by
the local academic department of general practice (which
in turn does not usually have a budget for this), and the
German College of General Practitioners and Family Physi-
cians. While many of these teaching GPs are willing to par-
ticipate in research, there is no financial or organisational
support for general practice-based research networks.
The small size of the academic departments makes
clinical trials particularly challenging: due to a two-stage
reviewing procedure in the federal funding programme,
the time lag between submission of the initial and main
proposals and the receipt of funding is at least a year.
Study centre recruitment must be successfully com-
pleted before a proposal is considered in the second re-
view round. This is very challenging in primary care,where study centres represent participating general prac-
tices run by individually motivated GPs. For most gen-
eral practice-based studies, a relatively high number of
practices/centres must be recruited to accommodate the
relatively low incidence/prevalence of most conditions in
a non-selected practice population. In order to conduct
a clinical drug trial, all research staff as well as all par-
ticipating GPs must be formally GCP trained by an
accredited centre. Depending on the region of Germany,
up to 16 hours of compulsory formal GCP training is
required, constituting a considerable commitment for
busy GPs. Another barrier is the high cost of the train-
ing, which adds to the trial costs.
German health care system
Other structural barriers relate to the German health
care system: there are no formal practice lists (as
patients do not need to register with a practice), and
GPs are not gatekeepers to specialist care [30] German
GPs compete with other GPs and community-based spe-
cialists for patients, and manage a very high patient flow
resulting in comparatively short consultation times
[31,32]. This implies that it is almost impossible to
define a reliable practice population/denominator, and
that there are no clear borders between primary and sec-
ondary specialist care. Patients with a condition that
qualifies them for trial participation may see a specialist
in the first place (reducing the number of eligible
patients in general practice), or in addition to seeing a
GP. In this very market-oriented health system, many
GPs are concerned about displeasing and losing patients.
They tend to consider practice-based research as a po-
tential conflict with, rather than contribution to, good
patient care and service orientation [33]. Most general
practitioners work in single-handed or small group pri-
vate practices and employ a few ‘practice assistants’ who
act as receptionists and fulfil some secretarial and med-
ical tasks, but do not work as independently as a nurse
or practice manager. Very few GPs have personal experi-
ence of research. Though many practices are fully com-
puterised, there is a multitude of different practice
software programmes, which provide neither support for
trial or research documentation nor offer compatibility
with other applications. All these factors - lack of re-
search awareness and experience, lack of supportive fa-
cilities and technology, and a work environment
perceived as competitive and high-pressure - are likely
to hamper trial participation of GPs and patients [34].
Structural prerequisites
Further to addressing the obstacles described above,
facilitating clinical trials in German general practice will
also require some fundamental change. The funding
environment to support trials needs to be improved and
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effectiveness trials. This is a political goal, which cannot
be achieved by a small group or within a short time.
Further implementation and upgrading of academic
departments of general practice would enable the
recruitment, training and retention of qualified research-
ers and research staff beyond single projects. This would
facilitate proposals for and the conduction of clinical
trials in primary care. Some structural or organisational
support for general practice-based research networks
could provide practices with a point of contact, informa-
tion, training facilities as well as support with recruit-
ment and inclusion phase of a trial. GPs and practice
staff will need professional recognition and financial
compensation for their training and the time invested in
research. A very recent survey on attitudes of German
GPs towards participation in clinical trials has been pub-
lished elsewhere [35].
Procedural prerequisites
A lot of support facilities and technology (including in-
formation technology), operating instructions and prede-
fined standard procedures exist for clinical trials in
hospital settings or specialised trial clinics. However,
most are setting-specific and cannot be conveyed to the
challenge of running a clinical trial in primary care sim-
ultaneously with patient care in a busy general practice
[36]. Peer support as well as a database of general
practice-specific research tools and standard operating
procedures (SOPs) can help researchers, research prac-
tices and their teams to run clinical trials successfully,
and to establish and disseminate specific expertise. A
summary of specific relevant key measures, for example
on a web platform, will be useful when planning and
conducting studies in Germany. Examples include the
incidence and prevalence of symptoms and diagnoses in
German primary care, in order to calculate sample or
effect sizes, pre-test probabilities or inter-cluster correl-
ation coefficients. The platform should contain SOPs,
templates, checklists and other supporting materials for
researchers. Appropriate and affordable GCP training fa-
cilities for GPs, able to cater to the special requirements
of trials in a general practice setting, are necessary, as
well as research training facilities for practice staff.
Training and material must be developed and accredited,
or permitted for cooperative use with accredited coord-
ination and training centres. Information technology and
practice software which incorporates and supports re-
cruitment and documentation for trials, that is, by
implementing search programmes and electronic case
report forms (CRFs), is substantial [14]. However, so far,
German software vendors consider the marketing poten-
tial of such adaptations as insufficient to warrant them
being a development priority.Discussion
Our problem analysis revealed that a substantial number
of barriers contribute to the low implementation of clin-
ical research in German general practice. Some issues
are deeply rooted in Germany’s health care and aca-
demic systems and traditions. However, new develop-
ments may facilitate change: the 2010 modification to
German drug law emphasises the need for comparative
effectiveness studies: within three months the majority
of newly licensed drugs must be assessed for superiority
compared to the current standard treatment for the par-
ticular condition [37,38]. Pricing is then based on the
results of this assessment. While this new legislation has
the potential to boost comparative effectiveness studies,
practical implications with regard to their organisation
and funding still remain unclear.
Nevertheless, interest in general practice and general
practice research is growing [39], fuelled by the need
to provide health care to an ageing and increasingly
multi-morbid population while containing costs. In the
last 10 years, the German federal government has run
a few successful programmes to build up research cap-
acity in general practice. However, these have not been
sustained. Nevertheless, with respect to health services
research or quality improvement studies in particular,
their structural [40] and scientific outputs [39,41] have
been remarkable. A recent publication of the German
Advisory Council for the Assessment of Developments
in the Health Care System points out the importance
of strong primary care [42]. The number of academic
departments of general practice is slowly, but steadily
increasing. Representation of GPs in decision-making and
funding bodies is gradually improving: very recently, the
German College of General Practitioners and Family Physi-
cians was granted the right to propose candidates to the re-
viewer boards of the German Research Foundation and one
candidate (EHP) was elected.
Some academic departments of general practice and
participants of the network have published clinical
studies that have received international attention
[17,19,21,43]. The first general practice-based study
funded by the clinical trials programme has recently
started [44]. Despite the lack of funding or structural
support, there are local initiatives to accredit research
practices and create practice-based research networks
[45]. The network group has conducted a survey, which
indicates that a substantial proportion of teaching GPs
and those attending continuous professional develop-
ment programmes run by the college or academic depart-
ments declare themselves motivated to participate in
clinical trials [34]. Within the context of one ongoing
trial run by several members of the group, a concept of
GCP training appropriate for general practice-based trials
has been developed and piloted [36].
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network group with very limited, temporary funding. Our
review of the international literature was conducted com-
prehensively and cannot be considered systematic, as rele-
vant papers are not always easily identified due to often
inconsistent or incomplete MeSH labeling [28]. However,
the network group collates considerable expertise with
members from most research-active departments or insti-
tutes of general practice in Germany, and a track record of
own clinical research. While this small group cannot
address structural barriers, it can provide some of the pro-
cedural prerequisites named above. A systematic review of
general practice-based clinical studies has been conducted
[25]. Key measures for general practice-based clinical trials
as well as useful tools to prepare proposals and to conduct
studies will be made available.
The first requirement of establishing inventories, pro-
viding materials, engaging practices interested in re-
search and networking, and providing information and
peer support has the potential to improve the quality
and success of grant applications. The network group
aims to further stimulate the development of additional
research capacity and research strategies for clinical
trials in general practice, and to be considered a research
group eligible for (structural) funding by the German
Research Foundation.
Ultimately, the network group aims to underpin co-
operation with coordination centres and funding bodies
by, for example, defining accreditation standards and
rewards for participating practices. It could also act as a
‘clearing house’, reviewing study proposals and protocols,
providing access to practices and facilitating bottom-up
communication of research needs in primary care to
funders and policy-making bodies [11].Conclusion
Successful conduction of clinical trials in general prac-
tice settings can be hampered by characteristics of a
market-based health care system, insufficient research
capacity and funding, and unfulfilled need for structural
support and established facilitative procedures. Though
we identified barriers related to the low implementation
of clinical trials in Germany, many of these, as well as
the prerequisites, may apply to other countries. Increas-
ing recognition of the importance of primary care and
its role in comparative effectiveness studies or transla-
tional research may facilitate new developments. In
Germany, recent developments in the research landscape
are encouraging.
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